Cart
Shopping cart

Beata Baszkiewicz

Zinzino Independent Partner

Vitajte! Som Váš nezávislý poradca a som tu, aby som Vás viedol na ceste za zdravím.

b.baszkiewicz@wp.pl
Textový podklad
Press releases - štvrtok, 5. júla 2018 13:00 CET

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT SECOND QUARTER 2018

Consistent sales growth during the second quarter; revenue increased 5% compared with the previous year. 

Zinzino’s total revenues for the second quarter of 2018 amounted to 144.7 (137.3) MSEK, corresponding to sales growth of 5% compared to the second quarter 2017.
Accumulated for January - June 2018, total revenues amounted to 282.2 (265.5) MSEK, corresponding to an increase of 6% compared with the previous year.
Several markets showed strong growth during the second quarter. The new European markets increased 201% in total. The growth was especially strong in Hungary where the sales amounted to 4.6 (0.1) MSEK during the second quarter. Germany increased by 100%. In the Baltic countries, the strong sales growth continued in Latvia which increased by 58%. Also, strong growth in the Netherlands which grew with 55% after having been a constant but non- growing market for a long time. The high turnover markets Sweden and Denmark increased by 13% and 10%, respectively during the second quarter.

For more information:
Dag Bergheim Pettersen, CEO Zinzino, Mobile: +47 (0) 932 25 700 www.zinzino.com

Pictures for publication free of charge: Marcus Tollbom, Mobile: +46 (0) 70 190 03 12  

Certified Adviser: Erik Penser Bank Aktiebolag
Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 13.00 on 5th of July, 2018.
   
  
Zinzino AB (publ.) is a direct sales company that operates throughout Europe and North America. Zinzino markets and sells prod­ucts in two product lines: Zinzino Health, with a focus on long-term health, and Zinzino Coffee, consisting of espresso machines, coffee and tea. Zinzino owns the Norwegian company BioActie Foods AS and the research and production unit Faun Pharma AS. Zinzino has more than 120 employees and currently trades in 33 markets across Europe and North America. Zinzino is based in Gothenburg, with additional offices in Helsinki, Riga, Oslo, and in Florida, USA. Zinzino is a public company and its shares are list­ed on Nasdaq First North. In 2016, Zinzino was awarded ‘’Superföretag 2015’’ by Veckans Affärer and ‘’Gazelle’’ award by Dagens Industri.


Tags
Zinzino